Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Epileptic Disord ; 15(3): 362-4, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24001596

RESUMO

Perampanel has recently been approved as an anticonvulsant drug for focal epilepsies. Phase III trials have shown good tolerability, although data regarding effects of high doses of perampanel are not available. Here, we describe the first case of a 34-year-old patient with perampanel intoxication and attempted suicide, in which the recommended daily dose of perampanel was exceeded ten-fold. Clinical signs of the intoxication and possible psychotropic effects are described.


Assuntos
Anticonvulsivantes/intoxicação , Epilepsias Parciais/tratamento farmacológico , Piridonas/intoxicação , Adulto , Anticonvulsivantes/farmacocinética , Anticonvulsivantes/uso terapêutico , Epilepsias Parciais/complicações , Epilepsias Parciais/etiologia , Epilepsia Tônico-Clônica/tratamento farmacológico , Epilepsia Tônico-Clônica/etiologia , Feminino , Escala de Coma de Glasgow , Humanos , Nitrilas , Piridonas/farmacocinética , Piridonas/uso terapêutico , Convulsões/fisiopatologia , Tentativa de Suicídio , Esclerose Tuberosa/complicações
2.
Epilepsy Res ; 114: 23-31, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26088882

RESUMO

OBJECTIVE: Analyses of the cerebrospinal fluid (CSF) are obligatory when epileptic seizures manifest for the first time in order to exclude life-threatening causes or treatable diseases such as acute infections or autoimmune encephalitis. However, there are only few systematic investigations on the effect of seizures themselves on CSF parameters and the significance of these parameters in differential diagnosis. METHODS: CSF samples of 309 patients with epileptic and 10 with psychogenic seizures were retrospectively analyzed. CSF samples were collected between 1999 and 2008. Cell counts, the albumin quotient, lactate and Tau-protein levels were determined. Findings were correlated with seizure types, seizure etiology (symptomatic, cryptogenic, occasional seizure), and seizure duration. RESULTS: Pathological findings were only observed in patients with epileptic but not with psychogenic seizures. The lactate concentration was elevated in 14%, the albumin quotient in 34%, and the Tau protein level in 36% of CSF samples. Cell counts were only slightly elevated in 6% of patients. Different seizure types influenced all parameters except for the cell count: In status epilepticus highest, in simple partial seizures lowest values were seen. Symptomatic partial and generalized epileptic seizures had significantly higher Tau-protein levels than cryptogenic partial seizures. In patients with repetitive and occasional epileptic seizures, higher Tau-protein levels were seen than in those with psychogenic seizures. Duration of epileptic seizures was positively correlated with the albumin quotient, lactate and Tau-protein levels. High variability of investigated CSF parameters within each subgroup rendered a clear separation between epileptic and psychogenic seizures impossible. SIGNIFICANCE: Elevated cell counts are infrequently observed in patients with epileptic seizures and should therefore not uncritically be interpreted as a postictal phenomenon. However, blood-CSF barrier disruption, increased glucose metabolism and elevation of neuronal damage markers are observed in considerable percentages of patients and depend on many factors such as etiology, seizure type and duration.


Assuntos
Epilepsia/líquido cefalorraquidiano , Convulsões/líquido cefalorraquidiano , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Albuminas/líquido cefalorraquidiano , Contagem de Células , Líquido Cefalorraquidiano/química , Líquido Cefalorraquidiano/citologia , Feminino , Humanos , Ácido Láctico/líquido cefalorraquidiano , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Estado Epiléptico/líquido cefalorraquidiano , Adulto Jovem , Proteínas tau/líquido cefalorraquidiano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA